Future Fund: Breakthrough is a £375 million UK-wide programme which encourages private investors to co-invest in high-growth, innovative firms.
The programme makes equity co-investments with private sector investors in growth stage R&D-intensive British companies operating in breakthrough technology sectors.
- Minimum total investment round size is £30 million.
- Maximum Future Fund: Breakthrough share of an investment round is 30%.
Future Fund: Breakthrough is delivered by British Patient Capital a commercial subsidiary of the British Business Bank.
It is a separate programme to the now closed Future Fund that provided convertible loans, valued up to £5 million, to a broad range of innovative companies to address the funding challenges caused by Covid-19.
Posted on: Friday 30th July 2021